Muscat Private Hospital to conduct a CME seminar
                   
ameinfo.com     May 15, 2008            

Dr Sultan al Maskari, Senior Consultant Orthopaedic Surgeon at Muscat Private Hospital will be conducting a continuing medical education (CME) on the 19th of May at Crowne Plaza Muscat Hotel. The topic for the CME is “Knee Osteoarthritis – Are patient’s getting timely advice?” Almost 25% of... [read full story]                

Add a comment to the article
Type the code shown

View all news articles about:

- Related Topics

View other selected articles:

                   

CombinatoRx Highlights Progress in Key Programs at 2008 R& D Day

genengnews.com     9 hrs ago          

News source: Business Wire CombinatoRx, Incorporated today provided a detailed review of selected therapeutic programs and a general company update at its annual Research and Development (R&D) day at its corporate headquarters...                

comments

NicOx Completes Enrollment Of Two Ambulatory Blood Pressure Measurement (ABPM) Studies For...

medicalnewstoday.com     14 hrs ago   7 related          

NicOx S.A. (Euronext Paris: COX) announced it has successfully completed the enrollment of 417 osteoarthritis (OA) patients with controlled hypertension in two clinical pharmacology studies in the United States, in line with...                

comments

                   

No justification for denying obese patients knee replacements

eurekalert.org     23 hrs ago   3 related          

There is no justification for denying obese patients knee replacement surgery: they benefit almost as much as anyone else from the procedure, concludes a small study published ahead of print in the Annals of the Rheumatic...                

comments

                   

Anika Therapeutics Reports 28% Increase in Revenue for Second Quarter 2008 (Business Wire)

yahoo.com     yesterday   4 related          

Tuesday July 22, 6:34 pm ET Joint Health Revenues Increase by 79% on Strong Domestic and European Sales BEDFORD, Mass.--(BUSINESS WIRE)--Anika Therapeutics, Inc. (Nasdaq: ANIK - The increase in product revenue for the quarter...                

comments